
Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.
Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
Medication Pearl of the Day: Obeticholic Acid (Ocaliva)
Indication: Obeticholic acid (Ocaliva), a farnesoid X receptor (FXR) agonist, is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
Insight:
Source:





